triazolam has been researched along with Developmental Psychomotor Disorders in 4 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Murphy, P | 1 |
Hindmarch, I | 1 |
Hyland, CM | 1 |
Greenblatt, DJ | 1 |
Shader, RI | 1 |
Divoll, M | 1 |
Harmatz, JS | 1 |
Halperin, JM | 1 |
Canon, J | 1 |
Iorio, LC | 1 |
Soldatos, CR | 1 |
Kales, A | 1 |
Bixler, EO | 1 |
Vela-Bueno, A | 1 |
1 review available for triazolam and Developmental Psychomotor Disorders
Article | Year |
---|---|
Behavioral side effects of benzodiazepine hypnotics.
Topics: Amnesia; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Flurazepam; Humans; Hypnotics and Sedatives; | 1985 |
2 trials available for triazolam and Developmental Psychomotor Disorders
Article | Year |
---|---|
Aspects of short-term use of two benzodiazepine hypnotics in the elderly.
Topics: Aged; Anti-Anxiety Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind | 1982 |
Adverse reactions to triazolam, flurazepam, and placebo in controlled clinical trials.
Topics: Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Dizziness; Dose-Response Relationship, Drug; D | 1984 |
1 other study available for triazolam and Developmental Psychomotor Disorders
Article | Year |
---|---|
Preclinical evaluation of behavioral deficits following hypnotic drug treatment.
Topics: Animals; Cebus; Conditioning, Operant; Discrimination Learning; Drug Evaluation, Preclinical; Fluraz | 1986 |